Hugh M. Evans (CLGN) details CollPlant share, RSU and option holdings
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
CollPlant Biotechnologies Ltd director Hugh M. Evans filed an initial ownership report showing his equity stake in the company. He directly holds 315,554 Ordinary Shares and 10,000 Restricted Share Units, of which 3,125 are vested and 6,875 vest in eleven equal quarterly installments from March 25, 2026 through September 25, 2028, subject to continued service.
Evans also holds two option awards to purchase Ordinary Shares: 24,000 options and 23,000 options, each with an exercise price of $6.39 per share and expiration dates on May 2, 2032 and May 26, 2031, respectively. One grant is fully vested, while 22,500 options from the other grant are vested and the remainder vest on May 2, 2026, subject to continued service. Additional Ordinary Shares are held indirectly: shares beneficially owned by his spouse and shares held by an irrevocable trust for his children, for which he disclaims beneficial ownership.
Positive
- None.
Negative
- None.
Insider Trade Summary
6 transactions reported
Mixed
6 txns
Insider
Evans Hugh M
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Options to Purchase Ordinary Shares | -- | -- | -- |
| holding | Options to Purchase Ordinary Shares | -- | -- | -- |
| holding | Restricted Share Units | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Options to Purchase Ordinary Shares — 23,000 shares (Direct, null);
Restricted Share Units — 10,000 shares (Direct, null);
Ordinary Shares — 315,554 shares (Direct, null);
Ordinary Shares — 10,000 shares (Indirect, See Footnote)
Footnotes (1)
- Of the restricted share units reported herein, 3,125 units are vested, and the remaining 6,875 units vest in eleven equal quarterly installments beginning March 25, 2026 and ending September 25, 2028, subject to the Reporting Person's continued service to the Issuer as of such vesting date. Ordinary shares beneficially owned by Reporting Person's spouse. Shares held by an irrevocable trust for the benefit of the reporting person's children of which the reporting person is a trustee. The reporting person disclaims any beneficial ownership in these shares. These options are fully vested and exercisable. 22,500 options are fully vested and exercisable. The remaining options shall vest and become exercisable on May 2, 2026, subject to the Reporting Person's continued service to the Issuer as of such vesting date.
Key Figures
Direct Ordinary Shares: 315,554 shares
Restricted Share Units: 10,000 units
Option Grant 1: 24,000 options at $6.39
+3 more
6 metrics
Direct Ordinary Shares
315,554 shares
Directly held after reported holdings
Restricted Share Units
10,000 units
3,125 vested; 6,875 vest quarterly from Mar 25 2026 to Sep 25 2028
Option Grant 1
24,000 options at $6.39
Options to purchase Ordinary Shares, expire May 2 2032; fully vested
Option Grant 2
23,000 options at $6.39
Options to purchase Ordinary Shares, expire May 26 2031; 22,500 vested, remainder vest May 2 2026
Indirect spouse holdings
Ordinary Shares (number not specified)
Ordinary shares beneficially owned by reporting person’s spouse
Trust-held shares
Ordinary Shares (number not specified)
Held by irrevocable trust for children; beneficial ownership disclaimed
Key Terms
Restricted Share Units, irrevocable trust, beneficially owned, disclaims any beneficial ownership, +2 more
6 terms
irrevocable trust financial
"Shares held by an irrevocable trust for the benefit of the reporting person's children"
beneficially owned financial
"Ordinary shares beneficially owned by Reporting Person's spouse."
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
disclaims any beneficial ownership financial
"The reporting person disclaims any beneficial ownership in these shares."
vest and become exercisable financial
"The remaining options shall vest and become exercisable on May 2, 2026"
FAQ
What does the Hugh M. Evans Form 3 for CollPlant Biotechnologies (CLGN) show?
The Form 3 shows Hugh M. Evans’ initial ownership in CollPlant, including directly held Ordinary Shares, Restricted Share Units, stock options, and certain indirect holdings. It details vesting schedules, option exercise prices, and expiration dates, clarifying how much equity exposure he currently has and may gain over time.
What stock options does Hugh M. Evans hold in CollPlant Biotechnologies (CLGN)?
Evans holds two option grants to purchase Ordinary Shares, covering 24,000 and 23,000 underlying shares at an exercise price of $6.39. One grant is fully vested; for the other, 22,500 options are vested and the remainder vest on May 2, 2026, assuming continued service.
How long do Hugh M. Evans’ CollPlant (CLGN) options remain exercisable?
His options have long-dated expirations. One grant expires on May 2, 2032, and the other on May 26, 2031. These dates define how long he can choose to exercise the options at the $6.39 strike price, subject to their vesting conditions being satisfied.